Taiwan Leader Biotech Corp. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 22.99 million compared to TWD 24.71 million a year ago. Net loss was TWD 14.77 million compared to TWD 13.85 million a year ago. Basic loss per share from continuing operations was TWD 0.3 compared to TWD 0.31 a year ago.